Consumer Health in Russia - Research and Markets

Low disposable incomes, compounded by the economic impact of COVID-19, has negatively impact sales of consumer health products in Russia in 2021, with consumers shifting to generics and less expensive branded products. Reduced purchasing power has also seen Russians showing a preference for proven pharmaceutical substances over herbal/traditional products.

The publisher's Consumer Health in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:

Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage:

Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

Get a detailed picture of the Consumer Health market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.

EXECUTIVE SUMMARY

Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?

MARKET INDICATORS

Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021

MARKET DATA

Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Distribution of Consumer Health by Format: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format and Category: % Value 2021
Table 9 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DISCLAIMERDEFINITIONS

SOURCES

Summary 1 Research Sources

ANALGESICS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Acetaminophen sales slump as stockpiling comes to an end while ibuprofen sees growth restricted by price controls
Combination products and naproxen benefit from lack of government price controls
Analgesics continues to see regular new product launches which is driving competition

PROSPECTS AND OPPORTUNITIES

Economic challenges set to undermine the growth potential of analgesics
Use of aspirin in the long-term treatment of heart conditions should support growth
Naproxen and combination products set for further growth while e-commerce stands to make further gains as regulation eases

CATEGORY DATA

Table 11 Sales of Analgesics by Category: Value 2016-2021
Table 12 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 13 NBO Company Shares of Analgesics: % Value 2017-2021
Table 14 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 15 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 16 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

COVID-19 measures and flu vaccinations help limit the spread of cold and flu
Contrasting fortunes for cough remedies and medicated confectionery
Despite declining sales competition remains strong in antihistamines/allergy remedies (systemic)

PROSPECTS AND OPPORTUNITIES

Category maturity and vaccinations set to be an obstacle to growth
Falling birth rates spells bad news for paediatric products
Allergies set to rise as consumer venture out again, while nasal sprays stands to benefit from new product development

CATEGORY DATA

Table 17 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 19 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 20 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 21 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026

DIGESTIVE REMEDIES IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

COVID-19 continues to apply downward pressure on diarrhoeal remedies
Mixed results across digestive remedies as COVID-19 affects demand in different ways
Sales of antacids benefiting from elevated stress levels

PROSPECTS AND OPPORTUNITIES

Slow uptake of COVID-19 vaccines could be an obstacle to growth
Laxatives set to benefit from unhealthy lifestyles and an ageing population
Convenience and efficacy key to growth

CATEGORY DATA

Table 23 Sales of Digestive Remedies by Category: Value 2016-2021
Table 24 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 25 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 26 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 27 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 28 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026

DERMATOLOGICALS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Poor diet and lack of exercise continues to drive demand for haemorrhoid treatments
Demand for topical germicidals/antiseptics softens as consumers learn to live with COVID-19
Antipruritics sees strong demand as consumers look to treat COVID-19 rashes

PROSPECTS AND OPPORTUNITIES

E-commerce could support stronger sales of sensitive products over the forecast period
Miramistin and Akriderm expected to remain key drivers of growth in dermatologicals
Easing of COVID-19 restrictions set to benefit dermatologicals

CATEGORY DATA

Table 29 Sales of Dermatologicals by Category: Value 2016-2021
Table 30 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 31 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 32 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 33 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 34 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 35 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026

NRT SMOKING CESSATION AIDS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Lack of controls over the sale of Rx NRT smoking cessation aids a barrier to growth
E-vapour products and e-cigarettes offer alternative means of quitting
Economic pressures help limit demand

PROSPECTS AND OPPORTUNITIES

Smoking population set to continue declining but competition from other products threatens the future of NRT smoking cessation aids
Economic pressures set to limit growth opportunities

NRT sprays and gum key to the future of NRT smoking cessation aids

CATEGORY INDICATORS

Table 36 Number of Smokers by Gender 2016-2021

CATEGORY DATA

Table 37 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 38 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 39 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 40 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 41 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026

SLEEP AIDS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Increased stress and anxiety due to COVID-19 creates demand for sleep aids
Price increase on ethanol puts downward pressure on volume sales

OTCPharm launches innovative new line as it extends its lead in 2021

PROSPECTS AND OPPORTUNITIES

Stress, blue light exposure and an ageing population all set to remain growth drivers
Economic pressures could restrict volume gains
Little change expected in the competitive landscape

CATEGORY DATA

Table 43 Sales of Sleep Aids: Value 2016-2021
Table 44 Sales of Sleep Aids: % Value Growth 2016-2021
Table 45 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 46 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 47 Forecast Sales of Sleep Aids: Value 2021-2026
Table 48 Forecast Sales of Sleep Aids: % Value Growth 2021-2026

EYE CARE IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Increased use of digital devices sustains demand but economic pressures take their toll
Allergy eye care suffers from being seen as a secondary treatment
Johnson & Johnson retains the lead thanks to consumer trust and loyalty

PROSPECTS AND OPPORTUNITIES

Standard eye care set to remain the dominant category driven by digitalisation and an ageing population
New packaging and added-value products could be key to fighting off competition from generics
Prevailing economic uncertainty expected to limit growth opportunities

CATEGORY DATA

Table 49 Sales of Eye Care by Category: Value 2016-2021
Table 50 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 51 NBO Company Shares of Eye Care: % Value 2017-2021
Table 52 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 53 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 54 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026

WOUND CARE IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Easing of COVID-19 restrictions sees a return to growth for wound care
First aid kits come under further pressure due to economic constraints
Little change in the competitive landscape as consumers turn to tried and tested products

PROSPECTS AND OPPORTUNITIES

Exercise, hygiene and a return to the workplace all potential growth drivers
First aid kits faces ongoing stagnation due to more affordable alternatives
Children key to sales but older generation also present opportunities for growth

CATEGORY DATA

Table 55 Sales of Wound Care by Category: Value 2016-2021
Table 56 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 57 NBO Company Shares of Wound Care: % Value 2017-2021
Table 58 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 59 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 60 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026

VITAMINS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Sales of multivitamins stabilise as consumers adapt to COVID-19
Competition remains strong in single vitamins as Vigantol returns to the market
A healthy diet still the preferred option, but expansion of e-commerce opens a new avenue for growth

PROSPECTS AND OPPORTUNITIES

More stable growth expected in vitamins due to economic pressures
Vitamin D deficiencies in Russia point towards growth opportunities
E-commerce and online marketing could help players to reach a new audience

CATEGORY DATA

Table 61 Sales of Vitamins by Category: Value 2016-2021
Table 62 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 63 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 64 NBO Company Shares of Vitamins: % Value 2017-2021
Table 65 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 66 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 67 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026

DIETARY SUPPLEMENTS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Sales stabilise in 2021 as fears around COVID-19 subside
New product development remains rife as dietary supplements continues to deliver strong sales
Glucosamine benefiting from demand for sport and fitness enthusiasts

PROSPECTS AND OPPORTUNITIES

Fish oils/omega fatty acids set to benefit from recommendations from health professionals
Economic pressures expected to take their toll
New direction for calcium supplements as players target new consumers

CATEGORY DATA

Table 68 Sales of Dietary Supplements by Category: Value 2016-2021
Table 69 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 70 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 71 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 72 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 73 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 74 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026

WEIGHT MANAGEMENT AND WELLBEING IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Home seclusion leads to rise in cases of overweight and obesity
Meal replacement benefits from healthier image
Herbalife remains king but focus shifts towards e-commerce due to COVID-19

PROSPECTS AND OPPORTUNITIES

Scepticism likely to grow over the value provided by weight loss supplements
Meal replacement key to the future of weight management and wellbeing
Healthy eating trend could threaten sales

CATEGORY DATA

Table 75 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 76 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 77 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 78 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 79 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026

SPORTS NUTRITION IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Sports nutrition expanding to reach a wider audience
E-commerce helps deliver strong growth in the face of COVID-19
Protein/energy bars driving growth as Sport-Express and Fitness-Food vie for the lead in sports nutrition

PROSPECTS AND OPPORTUNITIES

Sports nutrition remains full of potential but weak economy could undermine growth
Local players could offer stiff competition through offering more affordable prices
E-commerce could hold the key to growth and expansion

CATEGORY DATA

Table 81 Sales of Sports Nutrition by Category: Value 2016-2021
Table 82 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 83 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 84 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 85 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 86 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026

HERBAL/TRADITIONAL PRODUCTS IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Ease of access to more affordable raw materials limits demand for herbal/traditional products
Dietary supplements remain at the heart of the category
Competitive landscape remains highly fragmented

PROSPECTS AND OPPORTUNITIES

With incomes stretched speed and efficacy take precedence over natural claims
Long-term usage could favour the use of herbal/traditional products over standard treatments
Dietary supplements set to remain at the core of herbal/traditional products

CATEGORY DATA

Table 87 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 88 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 89 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 90 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 91 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 92 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026

PAEDIATRIC CONSUMER HEALTH IN RUSSIAKEY DATA FINDINGS

2021 DEVELOPMENTS

Demand softens as fears over COVID-19 subside while Russia’s declining birth rate remains an obstacle to growth
Nappy (diaper) rash treatments benefits from loyal base of consumers

VTF makes its mark with more product launches

PROSPECTS AND OPPORTUNITIES

Demographic trends threaten the growth of paediatric consumer health
Economic challenges expected to limit growth opportunities
Paediatric consumer health likely to continue facing competition from Rx treatments

CATEGORY DATA

Table 93 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 94 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 95 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2200EUR$2,412USD£1,901GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4400EUR$4,824USD£3,802GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€6600EUR$7,236USD£5,703GBP

Product coverage:

Data coverage:

Why buy this report?

Table of Contents

Related Topics

Related Reports

Consumer Health in Western Europe

The World Market for Consumer Health

OTC Consumer Healthcare Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Consumer Healthcare Global Market Report 2024

CBD Consumer Health Market Analysis & Forecast to 2024-2034